Home / Clinical trials / AOD-9604
Are there clinical trials for AOD-9604?
There are no clinical trials registered on ClinicalTrials.gov with AOD-9604 as an intervention. No registered trial means no trial results have been submitted to the US registry, so claims about AOD-9604 in humans are not supported by registered clinical evidence.
A search of ClinicalTrials.gov for AOD-9604 as a registered intervention returns no studies. This is the US registry where clinical trials are required to be listed, so an absence here is meaningful: it means no trial of AOD-9604 has been registered, not merely that results are pending.
Frequently asked questions
Are there clinical trials for AOD-9604?
There are no clinical trials registered on ClinicalTrials.gov with AOD-9604 as an intervention. No registered trial means no trial results have been submitted to the US registry, so claims about AOD-9604 in humans are not supported by registered clinical evidence.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where AOD-9604 is registered as an intervention. Last updated 2026-09-23.